Bastei Lübbe AG (BST)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 6.120 |
|---|---|
| 52-week range | 5.980 – 9.780 |
| Return, 1 month / 3 months | −4.7% / −4.9% |
| Return, 1 year / 3 years | −29.1% / +28.1% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 33.8% |
| Worst drawdown (1 year) | -34.0% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bastei Lübbe is a German publishing house based in Cologne. It publishes books, audiobooks and ebooks across fiction and non-fiction, including crime, fantasy, romance and children's titles, and it is known for long-running series such as the horror pulp John Sinclair and the science fiction saga Perry Rhodan. Its catalogue also includes audio dramas and digital formats, and its customers are readers and listeners in Germany and other German-speaking markets, reached through bookshops and online retailers.
Bastei Lübbe AG trades under the code BST on the Deutsche Börse Xetra in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bastei Lübbe AG (BST) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 6.120 on 27 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 490 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 29.1% and over the last three months it fell 4.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.2% | ||
| From 52-week high | -36.0% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.9% | ||
| 6-month return | -4.9% | ||
| 12-month return, skipping the last month | -25.6% | ||
| Stability (higher is calmer) | 50 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.0% | ||
| Liquidity | 23 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 3.3% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −4.7% |
| 3 months | −4.9% |
| 6 months | −4.9% |
| 1 year | −29.1% |
| 3 years | +28.1% |
| 5 years | +3.8% |
Signals
| 50-day / 200-day average | 6.419 / 6.595 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.186 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | EUR 0.2500 |
| 18 Sep 2025 | EUR 0.3600 |
| 12 Sep 2024 | EUR 0.3000 |
| 14 Sep 2023 | EUR 0.1600 |
| 15 Sep 2022 | EUR 0.4000 |
| 16 Sep 2021 | EUR 0.2900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.